Page 65 - 76_02
P. 65
VOL. 76 (2), 259-305, 2010 UTILIZACIÓN DE HIDROLASAS EN LA PREPARACIÓN...
70. Mischitz, M., et al. (1995) Asymmetric microbial hydrolysís of epoxides. Tetra-
hedron Asymmetry. 6: 1261.
71. Catt, J. D., et al. (1999) Preparation of benzofuran and dihydrobenzofuran
melatonergic agents. US.5856529, CAN 130:11015.
72. Goswami, A., et al. (1999) Stercospecific enzymatic hydrolysis of racemic
epoxide: a process for making chiral epoxide. Tetrahedron Asymmetry. 10: 3167.
73. Arch, J. R. S. (1997) $-3-adrenoceptors and other putative atypical $-adreno-
ceptors. Pharmacol. Rev. Commun. 9: 141.
74. Bloom, J. D., et al. (1989) Disodium (R.,R) 5-[2-(3-chlorophenyl)-2-hydroxye-
thyl] amino] propyl]-1,3- benzodioxole-2.2-dicarboxylate: a potent $-adrener-
gic agonist virtualIy specific for $-3-receptors. J. Med. Chem. 35: 3081.
75. Fisher, L. G., et al. (1994) BMS-187257, a potent, selective, and novel hetero-
cyclic $-3 adrenergic receptor agonist. Bioorg. Med. Chem. Lett. 6: 2253.
76. Patel, R. N., et al. (1998) Microbial synthesis of chiral intermediates for $-3-
receptor agonists. J. Am. Oil Chem. Soc. 75: 1473.
77. Campos, F., et al. (2000) An efficient enantioselective synthesis of (R,R)-for
formoterol, a potent bronchodilator, using lipases. Tetrahedron. Asymmetry.
11: 2705.
78. Bisacchi, G. (1999) Preparation of amidino and guanidino azetildinone com-
pounds as tryptase inhibitors. WO 9967215, Al 19991229, CAN 132:64103, AN
1999:819347.
79. Wirz, B. & Walther, W. (1992) Enzymic preparation of chiral 3-(hydroxyme-
thyl)piperidine derivatives. Tetrahedron Asymmetry. 3: 1049.
80. Goswami, A., et al. (2001) Chemical and enzymatic resolution of (R.S)-N.(tert-
butoxycarbonyl-3-hydroxymethylpiperidine. Organic Process. R&D. 5: 415.
81. Schenk, D., et al. (2001) Potential treatment opportunities for Alzheirner’s
disease through inhibition of secretases and A$ immunization. J. Mol. Neuros-
ci. 17: 259.
82. Audia, J., et al. Preparation of N- (phenylacetyl)di-and tripeptíde derivatives
for inhibiting $-amyloid peptide release. PCT lnt. Appl., WO 9822494, A2
19980528, CAN 129:41414, 126.
83. Patel, R. N., et al. (2000) Enzymatic resolution of racemic secondary alcohols
by lipase B from Candida antarctica. J. Am. Oil. Chem. Soc. 77: 1015.
84. Nanduri, V. B., et al. (2001) Biochemical approaches to the synthesis of ethyl
5-(S)-hydroxyl hexanoate and 5-(S) hydroxyhexanenitrile. Enzyme Microb.
Technol. 28 (7&8): 632.
85. Kagechika, H., et al. (1988) Retinobenzoic acids, 1: structure-activity relatio-
nship of aromatic amides with retinoidal activity. J. Med. Chem. 31: 2182.
86. Shudo, K. & Kagechika, H. (1989) Structure-activity relationships of a new
series of synthetic retinoids, in Chemistry and Biology of Synthetic Retinoids.
Dawson, M. I. & Okarnura, W. H., Eds. CRC Press, Boca Raton, FL.
87. Moon, R. C. & Itri, L. M. (1984) Retinoids and cancer. Retinoids. 2: 327.
88. Kagechika, H., et al. (1988) Retinobenzoic acids, 1: structure-activity relatio-
nships of aromatic amides with retinoidal activity. J. Med. Chem. 31: 2182.
89. Belema, M.; Zusi, F. C. & Tramposch, K. M. (2000) Active enantiomer of RAR
‘(-specific agonist, PCI Int. Appl. WO 0016769 Al 20000330 CAN 132:246379
AN 2000:209902.
303
